384 related articles for article (PubMed ID: 15669893)
1. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
Fava M; Thase ME; DeBattista C
J Clin Psychiatry; 2005 Jan; 66(1):85-93. PubMed ID: 15669893
[TBL] [Abstract][Full Text] [Related]
2. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
Thase ME; Fava M; DeBattista C; Arora S; Hughes RJ
CNS Spectr; 2006 Feb; 11(2):93-102. PubMed ID: 16520686
[TBL] [Abstract][Full Text] [Related]
3. Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors.
Konuk N; Atasoy N; Atik L; Akay O
Adv Ther; 2006; 23(4):646-54. PubMed ID: 17050507
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.
Ninan PT; Hassman HA; Glass SJ; McManus FC
J Clin Psychiatry; 2004 Mar; 65(3):414-20. PubMed ID: 15096082
[TBL] [Abstract][Full Text] [Related]
5. Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study.
Dunlop BW; Crits-Christoph P; Evans DL; Hirschowitz J; Solvason HB; Rickels K; Garlow SJ; Gallop RJ; Ninan PT
J Clin Psychopharmacol; 2007 Dec; 27(6):614-9. PubMed ID: 18004129
[TBL] [Abstract][Full Text] [Related]
6. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
Fava M; Thase ME; DeBattista C; Doghramji K; Arora S; Hughes RJ
Ann Clin Psychiatry; 2007; 19(3):153-9. PubMed ID: 17729016
[TBL] [Abstract][Full Text] [Related]
7. An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy.
Schwartz TL; Azhar N; Cole K; Hopkins G; Nihalani N; Simionescu M; Husain J; Jones N
J Clin Psychiatry; 2004 Sep; 65(9):1223-7. PubMed ID: 15367049
[TBL] [Abstract][Full Text] [Related]
8. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.
DeBattista C; Doghramji K; Menza MA; Rosenthal MH; Fieve RR;
J Clin Psychiatry; 2003 Sep; 64(9):1057-64. PubMed ID: 14628981
[TBL] [Abstract][Full Text] [Related]
9. Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study.
Lundt L
J Affect Disord; 2004 Aug; 81(2):173-8. PubMed ID: 15306145
[TBL] [Abstract][Full Text] [Related]
10. Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study.
Rabkin JG; McElhiney MC; Rabkin R; McGrath PJ
J Clin Psychiatry; 2010 Jun; 71(6):707-15. PubMed ID: 20492840
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
[TBL] [Abstract][Full Text] [Related]
12. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder.
Khan A; Cutler AJ; Kajdasz DK; Gallipoli S; Athanasiou M; Robinson DS; Whalen H; Reed CR
J Clin Psychiatry; 2011 Apr; 72(4):441-7. PubMed ID: 21527122
[TBL] [Abstract][Full Text] [Related]
14. An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.
Iosifescu DV; Nierenberg AA; Mischoulon D; Perlis RH; Papakostas GI; Ryan JL; Alpert JE; Fava M
J Clin Psychiatry; 2005 Aug; 66(8):1038-42. PubMed ID: 16086620
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study.
Rammohan KW; Rosenberg JH; Lynn DJ; Blumenfeld AM; Pollak CP; Nagaraja HN
J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):179-83. PubMed ID: 11796766
[TBL] [Abstract][Full Text] [Related]
16. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
17. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation.
Swanson JM; Greenhill LL; Lopez FA; Sedillo A; Earl CQ; Jiang JG; Biederman J
J Clin Psychiatry; 2006 Jan; 67(1):137-47. PubMed ID: 16426100
[TBL] [Abstract][Full Text] [Related]
18. Symptoms of fatigue and sleepiness in major depressive disorder.
Baldwin DS; Papakostas GI
J Clin Psychiatry; 2006; 67 Suppl 6():9-15. PubMed ID: 16848671
[TBL] [Abstract][Full Text] [Related]
19. Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial.
Rickels K; Athanasiou M; Robinson DS; Gibertini M; Whalen H; Reed CR
J Clin Psychiatry; 2009 Mar; 70(3):326-33. PubMed ID: 19284933
[TBL] [Abstract][Full Text] [Related]
20. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
Feighner JP; Overø K
J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]